ARCHIVES

NeoPharm To Begin Phase III Trial For Glioblastoma

This article is from The Cancer Letter archive.

Vol. 26 No. 12 | December 26, 2003

Download PDF Visit The Full Archive

Related Articles

ASCO Conquer Cancer Foundation Awards $6 Million To Researchers

April 22, 2011

DES Exposure Studies Below Payline; NCI Considers Contracts

March 6, 1992

Five Year Survival Up To 48 Percent; DeVita Has “No Doubt” It Is Really Over 50 Percent Now

December 2, 1983

Final Results from CLEOPATRA Phase III Trial Show Perjeta Increased OS 15.7 Months

September 26, 2014

MSK Issues Notice Of Dismissal To Neurosurgeon

September 8, 1995

Dingell To Challenge NCI, NSABP Handling Of Fraud, Delays

April 8, 1994